gms | German Medical Science

76. Jahresversammlung der Deutschen Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie e. V.

Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie e. V.

04.05. - 08.05.2005, Erfurt

Long-term experience with mandibular advancement splint (MAS) for treatment of obstructive sleep-related breathing disorders (oSRBD)

Meeting Abstract

Suche in Medline nach

  • corresponding author Malte Mahlerwein - HNO-Universitätsklinik Lübeck, Germany
  • Nitsch Stefan - HNO-Universitätsklinik Lübeck, Germany
  • Klaiber Susanne - HNO-Universitätsklinik Lübeck, Germany

Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie. 76. Jahresversammlung der Deutschen Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie e.V.. Erfurt, 04.-08.05.2005. Düsseldorf, Köln: German Medical Science; 2005. Doc05hno143

Die elektronische Version dieses Artikels ist vollständig und ist verfügbar unter: http://www.egms.de/de/meetings/hno2005/05hno238.shtml

Veröffentlicht: 22. September 2005

© 2005 Mahlerwein et al.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.de). Er darf vervielf&aauml;ltigt, verbreitet und &oauml;ffentlich zug&aauml;nglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden.


Gliederung

Text

Introduction: The MAS has gained in importance for treatment of oSRBD throughout the past years, especially for the mild and moderate forms. Studies have shown their positive effect on the upper airway during sleep, but predictors for successful treatment are still missing. Patient’s individual adequate supply may cause various problems.

Methods: We report about 110 patients, who we gave advice for MAS since 1998. Special interests are on effectiveness and long-term-acceptance. Furthermore the cooperation of health care providers (sleep laboratory (SL), dentist, resident, health insurance) is checked.

Results: Over the past 7 years the number of advice for MAS increased. Advancing splint technology and resulting patient’s comfort and effectiveness, increasing number of patients with mild and moderate oSRBD, as well as gaining more experience with MAS in SL are reasons for that. It is shown that just 51% of the patients have finally got a splint. In SL-controls 82% of them could be treated successfully. The individual effectiveness was not predictable.

Conclusion: The MAS has become an important option for treatment of oSRBD. Accurate selection of patients will assure success of treatment, which has to be controlled. The cooperation of health care providers concerning MAS needs to be improved.